January/February 2013 | Volume 2 Issue 1
By: Larry Miller, Principal Scientist Amgen
By: Paul S. Jones, Preclinical Sciences Manager Cancer Research UK
By: Christoph Saal, Head Of Analytical And Physico-chemical Characterisation Merck KGaA
By: Alain Pralong, Vice President for New Product Introduction and Technical Life Cycle M...
By: Karen Zink McCullough, Principal Consultant MMI Associates
By: Rob Bowen, Process Architect and Director Facilities Integration
By: Emiliano Toso, Head of the Molecular Biology; Fabio La Neve, Associate Scientist; F...
By: Ravi Kalyanaraman, Principal Scientist, Bristol-Myers Squibb; Mitesh Chauhan, Rese...